Daiichi Sankyo at SCOPE 2027

Mar 1–4, 2027 Orlando, FL ~5k attendees Website

Daiichi Sankyo brings 2 presentations to SCOPE 2027 in Orlando. Its sessions cover data-driven trial delivery in a mid-sized biopharma and the real role of AI in risk-based quality management. A concrete question is how much risk-based quality work AI is really doing.

OrganizationSCOPE 2027 Attendance
Daiichi Sankyo
Tokyo, Japan
daiichisankyo.com
Large pharma
Japanese pharmaceutical company with oncology and cardiovascular medicines, known for antibody-drug conjugates such as Enhertu.
Talk
Tue Mar 2
3:05pm–3:30pm
Panel
Wed Mar 3
12:05pm–12:30pm
AI in RBQM: How Much of the Work Is Really Being Done?
Quality & Monitoring

Explore the full SCOPE 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full SCOPE 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Daiichi Sankyo

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction